EDIT — EDITAS MEDICINE INC

Ownership history in Thrive Wealth Management, LLC  ·  8 quarters on record

This page tracks every 13F SEC filing in which Thrive Wealth Management, LLC reported a position in EDITAS MEDICINE INC (EDIT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2023 Q4)
Avg. % of fund
0.02%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 33,500 — 0% 0.01% $69K $2.05
2025 Q3 UNCHANGED 33,500 — 0% 0.02% $116K $3.47
2025 Q2 UNCHANGED 33,500 — 0% 0.01% $74K $2.20
2025 Q1 ADDED 33,500 +5,000 +17.5% 0.01% $39K $1.16
2024 Q4 ADDED 28,500 +10,000 +54.1% 0.01% $36K $1.27
2024 Q2 UNCHANGED 18,500 — 0% 0.02% $86K $4.67
2024 Q1 UNCHANGED 18,500 — 0% 0.03% $137K $7.42
2023 Q4 INITIATED 18,500 — — 0.04% $187K —
% of Fund (quarterly)    EDIT price (monthly, adj. close)

Other funds also holding EDIT

As of 2025 Q4 — sorted by position size

Green Alpha Advisors, LLC 3Y 0.3% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.1% EntryPoint Capital, LLC 0.07% Eversept Partners, LP 3Y 7Y 0.03% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.02% Hennion & Walsh Asset Management, Inc. 3Y 0.02% XTX Topco Ltd 3Y 0.01% DLK Investment Management, LLC 0.01% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.01% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.01%
← Back to Thrive Wealth Management, LLC Holdings